|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.84 USD | +1.48% |
|
-0.43% | -14.80% |
| Dec. 11 | Recent leadership changes at global consumer goods companies | RE |
| Dec. 10 | VersaBank Q4 Adjusted Earnings, Revenue, Advance | MT |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.79 | 9.88 | 10.01 | 10.77 | 10.91 | |||||
Return on Total Capital | 14.5 | 14.73 | 14.74 | 15.6 | 15.6 | |||||
Return On Equity % | 30.69 | 31.64 | 31.38 | 30.68 | 31.24 | |||||
Return on Common Equity | 30.8 | 31.69 | 31.34 | 30.58 | 31.14 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 51.43 | 47.65 | 48.05 | 51.69 | 51.34 | |||||
SG&A Margin | 26.74 | 24.34 | 24.81 | 26.76 | 25.7 | |||||
EBITDA Margin % | 28.28 | 26.81 | 26.55 | 28.37 | 29.01 | |||||
EBITA Margin % | 25.11 | 23.7 | 23.64 | 25.33 | 26.02 | |||||
EBIT Margin % | 24.69 | 23.31 | 23.24 | 24.93 | 25.64 | |||||
Income From Continuing Operations Margin % | 18.85 | 18.45 | 17.97 | 17.82 | 19.06 | |||||
Net Income Margin % | 18.79 | 18.38 | 17.87 | 17.7 | 18.95 | |||||
Net Avail. For Common Margin % | 18.44 | 18.03 | 17.52 | 17.37 | 18.61 | |||||
Normalized Net Income Margin | 15.05 | 14.2 | 14.14 | 15.33 | 15.68 | |||||
Levered Free Cash Flow Margin | 17.59 | 12.67 | 15.54 | 15.84 | 13.5 | |||||
Unlevered Free Cash Flow Margin | 18.01 | 13.01 | 16.12 | 16.53 | 14.17 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.63 | 0.68 | 0.69 | 0.69 | 0.68 | |||||
Fixed Assets Turnover | 3.46 | 3.61 | 3.67 | 3.68 | 3.52 | |||||
Receivables Turnover (Average Receivables) | 17.1 | 16.25 | 15.45 | 14.5 | 13.7 | |||||
Inventory Turnover (Average Inventory) | 6.44 | 6.5 | 6.09 | 5.76 | 5.63 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.7 | 0.65 | 0.63 | 0.73 | 0.7 | |||||
Quick Ratio | 0.45 | 0.37 | 0.38 | 0.46 | 0.44 | |||||
Operating Cash Flow to Current Liabilities | 0.55 | 0.51 | 0.47 | 0.59 | 0.49 | |||||
Days Sales Outstanding (Average Receivables) | 21.35 | 22.46 | 23.62 | 25.24 | 26.64 | |||||
Days Outstanding Inventory (Average Inventory) | 56.67 | 56.12 | 59.96 | 63.5 | 64.81 | |||||
Average Days Payable Outstanding | 125.65 | 121.63 | 125.85 | 135.24 | 134.37 | |||||
Cash Conversion Cycle (Average Days) | -47.64 | -43.05 | -42.27 | -46.5 | -42.92 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 70.39 | 68.92 | 75.27 | 66.71 | 69.86 | |||||
Total Debt / Total Capital | 41.31 | 40.8 | 42.94 | 40.01 | 41.13 | |||||
LT Debt/Equity | 50.86 | 50.03 | 53.06 | 51.94 | 49.98 | |||||
Long-Term Debt / Total Capital | 29.85 | 29.62 | 30.27 | 31.16 | 29.42 | |||||
Total Liabilities / Total Assets | 60.9 | 60.02 | 61.05 | 58.68 | 58.25 | |||||
EBIT / Interest Expense | 37.44 | 42.58 | 25.21 | 22.65 | 23.82 | |||||
EBITDA / Interest Expense | 43.52 | 49.68 | 29.21 | 26.15 | 27.36 | |||||
(EBITDA - Capex) / Interest Expense | 37.97 | 42.49 | 25.15 | 22.56 | 23.2 | |||||
Total Debt / EBITDA | 1.5 | 1.48 | 1.6 | 1.39 | 1.47 | |||||
Net Debt / EBITDA | 1.03 | 1.15 | 1.23 | 1 | 1.09 | |||||
Total Debt / (EBITDA - Capex) | 1.72 | 1.73 | 1.86 | 1.62 | 1.74 | |||||
Net Debt / (EBITDA - Capex) | 1.18 | 1.34 | 1.43 | 1.16 | 1.28 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 7.28 | 5.35 | 2.27 | 2.48 | 0.29 | |||||
Gross Profit, 1 Yr. Growth % | 7.79 | -2.38 | 3.12 | 10.23 | -0.39 | |||||
EBITDA, 1 Yr. Growth % | 8.33 | -0.13 | 1.26 | 9.52 | 2.56 | |||||
EBITA, 1 Yr. Growth % | 10.98 | -0.55 | 1.99 | 9.81 | 3.02 | |||||
EBIT, 1 Yr. Growth % | 11.46 | -0.53 | 1.94 | 9.92 | 3.15 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 9.53 | 3.07 | -0.37 | 1.6 | 7.29 | |||||
Net Income, 1 Yr. Growth % | 9.82 | 3.05 | -0.6 | 1.54 | 7.36 | |||||
Normalized Net Income, 1 Yr. Growth % | 11.15 | -0.64 | 2.11 | 11.1 | 2.55 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 10.87 | 5.56 | 1.61 | 2.04 | 8.12 | |||||
Accounts Receivable, 1 Yr. Growth % | 13.09 | 8.85 | 6.38 | 11.83 | 1.1 | |||||
Inventory, 1 Yr. Growth % | 8.82 | 15.73 | 2.15 | -0.81 | 7.61 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.42 | -2.4 | 3.35 | 1.49 | 7.8 | |||||
Total Assets, 1 Yr. Growth % | -1.15 | -1.76 | 3.09 | 1.28 | 2.34 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.47 | -7.48 | 4.83 | -30.42 | -4.18 | |||||
Common Equity, 1 Yr. Growth % | -0.25 | 0.52 | 0.46 | 7.68 | 3.53 | |||||
Cash From Operations, 1 Yr. Growth % | 5.56 | -8.97 | 0.75 | 17.79 | -10.22 | |||||
Capital Expenditures, 1 Yr. Growth % | -9.31 | 13.24 | -2.98 | 8.49 | 13.58 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 8.31 | -24.14 | 25.46 | 9.89 | -14.52 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 8.31 | -23.88 | 26.69 | 10.36 | -14 | |||||
Dividend Per Share, 1 Yr. Growth % | 7.05 | 8.66 | 4.48 | 4.02 | 6.47 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.05 | 6.31 | 3.8 | 2.37 | 1.38 | |||||
Gross Profit, 2 Yr. CAGR % | 9.05 | 3.46 | 0.51 | 6.88 | 5 | |||||
EBITDA, 2 Yr. CAGR % | 12.43 | 6.05 | 1.29 | 5.92 | 6.77 | |||||
EBITA, 2 Yr. CAGR % | 14.58 | 7.45 | 1.54 | 6.53 | 7.25 | |||||
EBIT, 2 Yr. CAGR % | 15.01 | 7.75 | 1.54 | 6.57 | 7.39 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 90.23 | 6.25 | 1.34 | 0.61 | 4.4 | |||||
Net Income, 2 Yr. CAGR % | 91.6 | 6.38 | 1.21 | 0.46 | 4.41 | |||||
Normalized Net Income, 2 Yr. CAGR % | 13.13 | 7.63 | 2.79 | 7.26 | 7.7 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 96.12 | 8.18 | 3.56 | 1.82 | 5.04 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.31 | 10.95 | 7.6 | 9.07 | 6.33 | |||||
Inventory, 2 Yr. CAGR % | 9.2 | 12.22 | 8.73 | 0.66 | 3.32 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.83 | 0.95 | 0.43 | 2.41 | 4.59 | |||||
Total Assets, 2 Yr. CAGR % | 1.81 | -1.46 | 0.64 | 2.18 | 1.81 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.27 | -1.21 | -1.52 | -14.59 | -18.34 | |||||
Common Equity, 2 Yr. CAGR % | -0.82 | 0.13 | 0.49 | 4.01 | 5.59 | |||||
Cash From Operations, 2 Yr. CAGR % | 9.79 | -1.97 | -4.23 | 8.94 | 2.84 | |||||
Capital Expenditures, 2 Yr. CAGR % | -8.75 | 1.34 | 4.82 | 2.6 | 11 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 13.82 | -7.57 | -1.73 | 15.36 | -2.27 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 13.42 | -7.45 | -1.09 | 16.26 | -1.79 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.78 | 7.85 | 6.55 | 4.25 | 5.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.43 | 5.81 | 4.95 | 3.35 | 1.67 | |||||
Gross Profit, 3 Yr. CAGR % | 6.51 | 5.1 | 3.35 | 3.65 | 4.4 | |||||
EBITDA, 3 Yr. CAGR % | 9.22 | 8.08 | 4.43 | 3.97 | 4.79 | |||||
EBITA, 3 Yr. CAGR % | 10.95 | 9.3 | 5.6 | 4.22 | 5.34 | |||||
EBIT, 3 Yr. CAGR % | 11.14 | 9.58 | 5.77 | 4.26 | 5.42 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 13.33 | 55.08 | 4 | 1.42 | 2.79 | |||||
Net Income, 3 Yr. CAGR % | 13.63 | 55.81 | 4 | 1.32 | 2.71 | |||||
Normalized Net Income, 3 Yr. CAGR % | 12.18 | 8.34 | 5.67 | 5.49 | 5.67 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.44 | 59.53 | 5.94 | 3.05 | 3.88 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.28 | 1.28 | 9.4 | 8.99 | 6.34 | |||||
Inventory, 3 Yr. CAGR % | 8.09 | 11.34 | 8.76 | 5.45 | 2.93 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.98 | 1.06 | 1.75 | 0.78 | 4.18 | |||||
Total Assets, 3 Yr. CAGR % | 0.28 | 0.61 | 0.04 | 0.85 | 2.23 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2.4 | -1.09 | 0.76 | -12.28 | -11.25 | |||||
Common Equity, 3 Yr. CAGR % | -3.93 | -0.38 | 0.24 | 2.83 | 3.85 | |||||
Cash From Operations, 3 Yr. CAGR % | 7.31 | 3.14 | -1.07 | 2.61 | 2.13 | |||||
Capital Expenditures, 3 Yr. CAGR % | -9.15 | -1.94 | -0.12 | 6.03 | 6.13 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.04 | -0.58 | 2.34 | 0.29 | 4.39 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 14.58 | -0.7 | 2.76 | 0.93 | 5.14 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.18 | 6.73 | 6.72 | 5.7 | 4.99 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.11 | 4.27 | 4.18 | 4.42 | 3.5 | |||||
Gross Profit, 5 Yr. CAGR % | 3.86 | 3.34 | 3.99 | 5.7 | 3.92 | |||||
EBITDA, 5 Yr. CAGR % | 5.42 | 5.33 | 5.67 | 6.96 | 5.05 | |||||
EBITA, 5 Yr. CAGR % | 6.66 | 6.17 | 6.74 | 7.9 | 5.9 | |||||
EBIT, 5 Yr. CAGR % | 6.91 | 6.31 | 6.84 | 8.08 | 6.06 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 7.44 | 7.73 | 8.37 | 30.44 | 4.16 | |||||
Net Income, 5 Yr. CAGR % | 6.37 | -0.77 | 8.49 | 30.73 | 4.16 | |||||
Normalized Net Income, 5 Yr. CAGR % | 7.24 | 5.92 | 7.4 | 7.55 | 6.1 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.52 | 9.5 | 9.96 | 33.3 | 5.58 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.56 | 2.28 | 3.15 | 4.32 | 8.16 | |||||
Inventory, 5 Yr. CAGR % | 4.87 | 8.41 | 8.34 | 6.94 | 6.55 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.02 | 1.99 | 1.95 | 1.6 | 2.88 | |||||
Total Assets, 5 Yr. CAGR % | -1.26 | -0.54 | 0.42 | 1.23 | 0.74 | |||||
Tangible Book Value, 5 Yr. CAGR % | 8.67 | 3.69 | 0.81 | -6.73 | -7.37 | |||||
Common Equity, 5 Yr. CAGR % | -4.17 | -3.33 | -2.19 | 1.36 | 2.35 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.54 | 5.57 | 2.53 | 5.42 | 0.47 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.4 | -1.39 | -3.8 | -0.15 | 4.19 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.51 | -7.16 | 7.7 | 5.19 | -0.88 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.91 | -7.03 | 7.72 | 5.45 | -0.39 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.04 | 5.48 | 5.73 | 5.73 | 6.12 |
- Stock Market
- Equities
- PG Stock
- Financials Procter & Gamble Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















